August 12 Product: Sandozs Enzeevu Indication: Neovascular age-related macular degeneration Sandoz bolstered its biosimilar position in the ophthalmology space Monday with an approval for Enzeevu, a 2-mg vial kit and prefilled syringe for intravitreal injection to treat neovascular age-related macular degeneration (nAMD)
Another systematic review and network meta-analysis concluded that PRP was the most effective injectable treatment for knee OA compared to corticosteroids and HA (PMID: 35581332)
In addition, stem cell therapy may be considered in certain cases as an innovative complementary approach aimed at addressing underlying physiological factors associated with ASD
For cardiovascular health specifically, Canadians have well-established conventional options through the healthcare system
It enhances the expression of growth hormone receptors and is mainly responsible for muscle, injury, and tendon healing, and activating angiogenesis
In senescent cell assays, Epithalon restores normal progression through G1/S phases, providing a tool for cell-aging protocols
